Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentered Observational Cohort Study on the Efficacy, Safety and Durability of the "UniLine" Epoxy-treated Prosthesis Made With Xenopericardium in the Treatment of Isolated Aortic and Mitral Valve Disease (UniLine RetroFit)

NCT05895487 is registered in ClinicalTrials.gov with Closed Joint-Stock Company NeoCor as lead sponsor.

NCT NCT05895487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentered Observational Cohort Study on the Efficacy, Safety and Durability of the "UniLine" Epoxy-treated Prosthesis Made With Xenopericardium in the Treatment of Isolated Aortic and Mitral Valve Disease (UniLine RetroFit)
Lead sponsor
Closed Joint-Stock Company NeoCor
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2022
Completion date
May 1, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diseases of mitral and aortic valves, mitral valve insufficiency and aortic valve insufficiency, other congenital malformations of aortic and mitral valves, rheumatic disorders of mitral and aortic valves, valvular heart disease (aortic and mitral valves)